Similar Search Results

Drug formulary restrictions as a cost-containment policy in Medicaid programs

Moore, William J. - In: The journal of law & economics 36 (1993) 1, pp. 71-97

Persistent link: https://www.econbiz.de/10001164646

Initial impact of a medicaid maintenance dose program for H 2 antagonist prescriptions

Kotzan, Jeffrey A. (contributor) - In: Journal of research in pharmaceutical economics 5 (1993) 1, pp. 43-58

Persistent link: https://www.econbiz.de/10001148423

Initial impact of a medicaid prior authorization program for NSAID prescriptions

Kotzan, Jeffrey A. (contributor) - In: Journal of research in pharmaceutical economics 5 (1993) 1, pp. 25-41

Persistent link: https://www.econbiz.de/10001148424

Prescription drug expenditures and ‘universal’ coverage : the Quebec experience in Canada

Devlin, Rose Anne; Wang, Yiwen - 2016

Persistent link: https://www.econbiz.de/10011542856

Patient outcomes and cost effects of medicaid formulary restrictions on antidepressants

Seabury, Seth A.; Lakdawalla, Darius; Walter, Deborah; … - In: Forum for health economics & policy : an evolving … 17 (2014) 2, pp. 153-168

Persistent link: https://www.econbiz.de/10010458253

A study of prescription dispensing cost variability among Texas Medicaid pharmacy providers

Lawson, Kenneth A. - 1992

Persistent link: https://www.econbiz.de/10000868176

Monopoly pricing under a Medicaid-style most-favored-customer clause and its welfare implication

Klibanoff, Peter; Kundu, Tapas - 2009

To control Medicaid's increasing expenditure on reimbursement of outpatient prescription drugs, the Omnibus Budget Reconciliation Act of 1990 included a rebate program that featured a most favored customer (MFC) clause. This clause guarantees that Medicaid gets a fixed rebate on each unit of...

Persistent link: https://www.econbiz.de/10003898336

Monopoly pricing under a medicaid-style most-favored-customer clause and its welfare implication

Klibanoff, Peter; Kundu, Tapas - In: The B.E. journal of economic analysis & policy 10 (2010) 1, pp. 1-41

Persistent link: https://www.econbiz.de/10009552775

How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives

Özden Gür Ali; Topaler, Başak - In: The European journal of health economics : HEPAC ; … 12 (2011) 6, pp. 553-562

Persistent link: https://www.econbiz.de/10009376933

Essays in political economy and regulation

Kundu, Tapas - 2007

Persistent link: https://www.econbiz.de/10009273646